Nevirapine induced Stevens Johnson Syndrome
Journal Title: Journal of Pharmacovigilance and Drug Research - Year 2020, Vol 1, Issue 20201206
Abstract
A 56-year-old male patient presented with a complaint of lesions all over the body with a burning sensation for 4 days. He was on an ART regimen, containing zidovudine, lamivudine, and efavirenz combination for 4 years. But patient accidentally started nevirapine and after 10 days he developed maculopapular lesions which were diagnosed as SJS syndrome. There was a history of rash with nevirapine when ART was started initially in 2012. This incident of an adverse event could be assigned a term "probable" according to the WHO-UMC scale for causality assessment as the re-challenge was found positive. Severe and life-threatening SJS is more common with nevirapine than with other NNRTIs. Physicians and patients must be aware of this adverse effect on early diagnosis and treatment.
Authors and Affiliations
Himani Prajapati1, Neetu Bala2*, Dinesh Kansal2
Keywords
Related Articles
- EP ID EP690861
- DOI 10.5281/zenodo.4299042
- Views 179
- Downloads 0
Cutaneous Adverse Drug Reactions in a Tertiary Care Hospital: An Observational Study
Cutaneous adverse drug reactions (CADRs) are one of the most common ADRs caused by drugs causing a lot of morbidity and mortality. The overall incidence of CADRs in developed countries is 1-3 %, while that in the develop...
Overview of important methods used for Causality Assessment of adverse drug events in Pharmacovigilance
The method of assessing causality between adverse events and suspect drugs is the most challenging task in pharmacovigilance. It requires attentive consideration of both the adverse events and suspect drugs, patient-rela...
Design, synthesis, characterization and in vivo studies of some hydroxylated chalcone derivatives as hypoglycemic agents
Low molecular weight ligands (LMWL) have citadel reputation in the modulation of numerous therapeutic targets as a result of their smart uniqueness. The hydroxylated chalcone derivatives have been reported to be therapeu...
Toxic epidermal necrolysis associated with combination therapy of spironolactone and torsemide
Dytor plus tablet is a fixed-dose combination of torsemide and spironolactone used for generalized edema. TEN is a serious, potentially life-threatening dermatological disorder. Here we present a case report of a 47-year...
A Review on Potential Drug Delivery System as a Treatment of Intercellular Bacterial Infection
Intracellular bacterial pathogens are hard to treat because of the inability of conventional antimicrobial agents belonging to widely used classes, like aminoglycosides and β-lactams, fluoroquinolones, or macrolides to p...